CAPR Capricor Therapeutics, Inc.
$8.60
Capricor Therapeutics, Inc. (CAPR) Earnings News
Earnings press releases, previews and reviews for Capricor Therapeutics, Inc. (CAPR), newest first. Our most recent is preview: Capricor's Q3 Report Must Show Whether Its Narrower FDA Path for Deramiocel Is Holding.
Wednesday
November 4, 2026
2:33 PM ET
Capricor's Q3 Report Must Show Whether Its Narrower FDA Path for Deramiocel Is Holding
Earnings Whispers · Preview
Tuesday
November 3, 2026
9:00 AM ET
Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
Thursday
August 13, 2026
4:05 PM ET
Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Monday
August 10, 2026
8:30 AM ET
Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13
Tuesday
May 12, 2026
4:05 PM ET
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update